Cargando…

Quality of Preventive and Chronic Illness Care for Insured Adults With Opioid Use Disorder

IMPORTANCE: Nearly all initiatives to improve care for individuals with opioid use disorder (OUD) have focused on improving OUD identification and treatment. Whether individuals with OUD have lower quality of care than individuals without OUD remains unclear. OBJECTIVE: To measure quality of non-OUD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anderson, Kelly E., Alexander, G. Caleb, Niles, Lauren, Scholle, Sarah H., Saloner, Brendan, Dy, Sydney M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033422/ https://www.ncbi.nlm.nih.gov/pubmed/33830229 http://dx.doi.org/10.1001/jamanetworkopen.2021.4925

Ejemplares similares

Changes in Buprenorphine-Naloxone and Opioid Pain Reliever Prescriptions After the Affordable Care Act Medicaid Expansion
por: Saloner, Brendan, et al.
Publicado: (2018)

Trends in Engagement With Opioid Use Disorder Treatment Among Medicaid Beneficiaries During the COVID-19 Pandemic
por: Tilhou, Alyssa Shell, et al.
Publicado: (2022)

Association of Pregnancy and Insurance Status With Treatment Access for Opioid Use Disorder
por: Patrick, Stephen W., et al.
Publicado: (2020)

Incidence of Treatment for Opioid Use Disorder Following Nonfatal Overdose in Commercially Insured Patients
por: Kilaru, Austin S., et al.
Publicado: (2020)

Estimated Use of Prescription Medications Among Individuals Incarcerated in Jails and State Prisons in the US
por: Curran, Jill, et al.
Publicado: (2023)

Association Between Hospital Adoption of an Emergency Department Treatment Pathway for Opioid Use Disorder and Patient Initiation of Buprenorphine After Discharge
por: Solomon, Keisha T., et al.
Publicado: (2023)

Naloxone Prescriptions Among Commercially Insured Individuals at High Risk of Opioid Overdose
por: Follman, Sarah, et al.
Publicado: (2019)

Changes in Surgical Opioid Prescribing and Patient-Reported Outcomes After Implementation of an Insurer Opioid Prescribing Limit
por: Chua, Kao-Ping, et al.
Publicado: (2023)

29. Use of Buprenorphine for Opioid Use Disorder among US Adolescents and Young Adults During the COVID-19 Pandemic
por: Alinsky, Rachel, et al.
Publicado: (2022)

Association of Criminal Statutes for Opioid Use Disorder With Prevalence and Treatment Among Pregnant Women With Commercial Insurance in the United States
por: Gressler, Laura E., et al.
Publicado: (2019)

Treatment of Opioid Use Disorder With Buprenorphine Among US Adolescents and Young Adults During the Early COVID-19 Pandemic
por: Alinsky, Rachel H., et al.
Publicado: (2022)

Indication-Specific Opioid Prescribing for US Patients With Medicaid or Private Insurance, 2017
por: Mikosz, Christina A., et al.
Publicado: (2020)

Evaluation of a Chronic Pain Screening Program Implemented in Primary Care
por: Bifulco, Lauren, et al.
Publicado: (2021)

Quality of Opioid Use Disorder Treatment for Persons With and Without Disabling Conditions
por: Thomas, Cindy Parks, et al.
Publicado: (2023)

Mobile Telemedicine for Buprenorphine Treatment in Rural Populations With Opioid Use Disorder
por: Weintraub, Eric, et al.
Publicado: (2021)

Use of Medication for Opioid Use Disorder Among US Adolescents and Adults With Need for Opioid Treatment, 2019
por: Mauro, Pia M., et al.
Publicado: (2022)

Association of Formulary Exclusions and Restrictions for Opioid Alternatives With Opioid Prescribing Among Medicare Beneficiaries
por: Rao, Tanvi, et al.
Publicado: (2020)

Opioid Dose Trajectories and Associations With Mortality, Opioid Use Disorder, Continued Opioid Therapy, and Health Plan Disenrollment
por: Binswanger, Ingrid A., et al.
Publicado: (2022)

Telemedicine Use and Quality of Opioid Use Disorder Treatment in the US During the COVID-19 Pandemic
por: Hailu, Ruth, et al.
Publicado: (2023)

Chronic pain diagnoses and opioid dispensings among insured individuals with serious mental illness
por: Owen-Smith, Ashli, et al.
Publicado: (2020)

Prevention of Prescription Opioid Misuse and Projected Overdose Deaths in the United States
por: Chen, Qiushi, et al.
Publicado: (2019)

Prescribing of Opioid Analgesics and Buprenorphine for Opioid Use Disorder During the COVID-19 Pandemic
por: Currie, Janet M., et al.
Publicado: (2021)

Jail-based treatment for opioid use disorder in the era of bail reform: a qualitative study of barriers and facilitators to implementation of a state-wide medication treatment initiative
por: Krawczyk, Noa, et al.
Publicado: (2022)

Polysubstance Use Among Patients Treated With Buprenorphine From a National Urine Drug Test Database
por: Saloner, Brendan, et al.
Publicado: (2021)

Association of Opioid Dose Reduction With Opioid Overdose and Opioid Use Disorder Among Patients Receiving High-Dose, Long-term Opioid Therapy in North Carolina
por: DiPrete, Bethany L., et al.
Publicado: (2022)

Comparison of Opioids Prescribed for Patients at Risk for Opioid Misuse Before and After Publication of the Centers for Disease Control and Prevention’s Opioid Prescribing Guidelines
por: Scherrer, Jeffrey F., et al.
Publicado: (2020)

Social Risk Adjustment of Quality Measures for Diabetes and Cardiovascular Disease in a Commercially Insured US Population
por: Nguyen, Christina A., et al.
Publicado: (2019)

High-Dose Buprenorphine Induction in the Emergency Department for Treatment of Opioid Use Disorder
por: Herring, Andrew A., et al.
Publicado: (2021)

Association of US Medical Marijuana Laws With Nonmedical Prescription Opioid Use and Prescription Opioid Use Disorder
por: Segura, Luis E., et al.
Publicado: (2019)

Comparison of Utilization, Costs, and Quality of Medicaid vs Subsidized Private Health Insurance for Low-Income Adults
por: Allen, Heidi, et al.
Publicado: (2021)

Association of Postsurgical Opioid Refills for Patients With Risk of Opioid Misuse and Chronic Opioid Use Among Family Members
por: Agniel, Denis, et al.
Publicado: (2022)

Prior authorization restrictions on medications for opioid use disorder: trends in state laws from 2005 to 2019
por: Andraka-Christou, Barbara, et al.
Publicado: (2023)

Characteristics of US Counties With High Opioid Overdose Mortality and Low Capacity to Deliver Medications for Opioid Use Disorder
por: Haffajee, Rebecca L., et al.
Publicado: (2019)

Association of the 2016 US Centers for Disease Control and Prevention Opioid Prescribing Guideline With Changes in Opioid Dispensing After Surgery
por: Sutherland, Tori N., et al.
Publicado: (2021)

Implementation Facilitation to Promote Emergency Department–Initiated Buprenorphine for Opioid Use Disorder
por: D’Onofrio, Gail, et al.
Publicado: (2023)

A national survey of state laws regarding medications for opioid use disorder in problem-solving courts
por: Andraka-Christou, Barbara, et al.
Publicado: (2022)

Assessment of Probable Opioid Use Disorder Using Electronic Health Record Documentation
por: Palumbo, Sarah A., et al.
Publicado: (2020)

Illness perception, coping, and quality of life in early-stage Mycosis fungoides()()
por: Segal, Oz, et al.
Publicado: (2021)

Integrating Opioid Use Disorder Treatment Into Primary Care Settings
por: Austin, Elizabeth J., et al.
Publicado: (2023)

Perspectives About Emergency Department Care Encounters Among Adults With Opioid Use Disorder
por: Hawk, Kathryn, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k6jk02g08uq8rkrdmvii60uvvi